Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2, which seems to be a minor metadata update with no substantive changes to study design, criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page lists an administrative revision update from v3.4.0 to v3.4.1; no changes to study details, eligibility criteria, or user interactions are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedShow glossary was added; the page now includes 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' in the footer. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 'Last Update Posted' timestamp and removes the 'Last Update Posted (Estimated)' timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe only visible change is the page’s revision tag updating from v3.3.3 to v3.3.4. There is no change to the study content, eligibility criteria, locations, or primary outcomes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.